This study is sought to investigate any predictors including biomarkers for atrial high rate episodes (AHRE) occurrence in patients without prior history of atrial tachyarrhythmias receiving cardiac implantable electronic device (CIED).
Atrial high rate episodes (AHRE) are noticed up to 70% in patients receiving cardiac implantable electronic device (CIED) even in the absence of prior history of atrial tachyarrhythmias. AHRE is clinically important because it is considered to be associated with clinical atrial fibrillation, stroke, mortality, and heart failure hospitalization. Therefore, predictors of AHRE might be useful for early detection of AHRE susceptable CIED recipients. Biomarkers as well as clinical characteristics will be analyzed.
Study Type
OBSERVATIONAL
Enrollment
100
implantable cardiac electronic device recipients for any clinical indication
Jinhee Ahn
Busan, South Korea
The occurrence of atrial high rate episode
Time frame: 12 months
Factors predicting the occurrence of atrial high rate episode
factors including biomarkers such as FGF-23 and soluble ST-2, and single nucleotide polymorphism
Time frame: 12 months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.